IDEAS home Printed from https://ideas.repec.org/p/ohe/monogr/000481.html
   My bibliography  Save this paper

Institutions for Industrial Competitiveness in the International Pharmaceutical Industry

Author

Listed:
  • Jorge Mestre-Ferrandiz;Jon Sussex

Abstract

One of the main characteristics of the pharmaceutical industry, including biotechnology, is the important role played by public institutions. Their role is not only focused on encouraging research and development (R&D), but also on regulation of the final product market. The special characteristics of the pharmaceutical industry and its economic importance for many nations imply that governments have a strong interest in supporting the efficient functioning of the industry. Many, different, economic agents are involved. Public authorities and institutions interact with a wide variety of firms in this sector. Both public authorities and firms deal with universities and other research institutions. We need to understand these interactions because how they work and are structured raises important questions of particular interest to policy makers as well as economists. Competencies and incentives are key words. The aim of this collection of papers is to analyse how the role of public institutions can help provide both the correct competencies and the right incentives for the pharmaceutical industry to be competitive and innovative and so promote economic growth.

Suggested Citation

  • Jorge Mestre-Ferrandiz;Jon Sussex, 2003. "Institutions for Industrial Competitiveness in the International Pharmaceutical Industry," Monograph 000481, Office of Health Economics.
    • Handle: RePEc:ohe:monogr:000481
    as

    Download full text from publisher

    File URL: https://www.ohe.org/publications/institutions-industrial-competitiveness-international-pharmaceutical-industry/attachment-284-2003_institutions_for_industrial_compet_mestre-ferran/
    Download Restriction: no
    ---><---

    More about this item

    Keywords

    Institutions for Industrial Competitiveness in the International Pharmaceutical Industry;

    JEL classification:

    • I1 - Health, Education, and Welfare - - Health

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ohe:monogr:000481. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Publications Manager (email available below). General contact details of provider: https://edirc.repec.org/data/ohecouk.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.